Pricing Log in Create free account

Agenus Inc. (AGEN) vs Scribe Therapeutics Inc. (SCTX)

Agenus Inc. and Scribe Therapeutics Inc. are both Biotechnology companies. Agenus Inc. and Scribe Therapeutics Inc. are of similar size ($293.1M and $290.8M). Across the 4 metrics below, Agenus Inc. leads on 3 and Scribe Therapeutics Inc. on 1.

Valuation

Metric AGEN SCTX Biotechnology median
P/E 10.70 — 10.60
P/S 3.33 n/m 9.40
P/B n/m n/m 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA 7.99 n/m 0.66
EV/Sales 3.24 n/m 9.02
Earnings yield 9.35% — (32.88%)
Free cash flow yield (23.17%) 0.00% (23.13%)

Profitability

Metric AGEN SCTX Biotechnology median
Gross margin 100.00% — 68.51%
Operating margin 38.94% — 0.00%
Net margin 21.99% — 0.00%
Free cash flow margin (77.54%) — 0.00%
Return on equity (14.99%) — (51.96%)
Return on assets 12.29% — (46.06%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric AGEN SCTX Biotechnology median
Revenue growth (TTM) 25.38% — 6.76%
EPS growth (last fiscal year) 100.00% — 29.88%
Revenue growth, 5-year CAGR 5.31% — 9.75%
Net income growth, 5-year CAGR 0.00% — 0.00%

Health

Metric AGEN SCTX Biotechnology median
Debt to equity (0.22) 0.00 0.00
Current ratio 0.73 0.57 4.97
Net debt to EBITDA (4.10) 0.00 1.01

Dividend

Metric AGEN SCTX Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric AGEN SCTX Biotechnology median
Market cap 290.84m 293.06m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack